POEM Anterior Versus Posterior Approach

Achalasia Clinical Trial

Official title:

Comparison of Outcome and Complications of Anterior Versus Posterior Myotomy in Per-oral Endoscopic Myotomy (POEM) Endoscopic Procedure for Treatment of Achalasia: Randomized Single Blinded Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02454335
• Other study ID #: NA_00093759
• Status: Completed
• Phase: N/A
• First received: May 10, 2015
• Last updated: December 28, 2017
• Start date: January 2015
• Est. completion date: November 2017

Study information

• Verified date: December 2017
• Source: Johns Hopkins University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Per-oral endoscopic myotomy (POEM) is an incisionless procedure used to treat esophageal achalasia, performed by GI endoscopist without cutting any surface of the human body. The main constituent of the procedure is the myotomy part, through which the endoscopist cuts the muscle fibers in the submucosa. Since this procedure is completely new to the area of treatment of achalasia, it is unknown whether a posterior or an anterior myotomy is better in relieving the symptoms. Thenceforth, this study aims at randomizing patients with achalasia presenting for POEM to getting either the posterior or the anterior myotomy. Patients will be followed up for symptoms and complications; data will be extracted and the appropriate analysis will be employed to determine if there is any difference of outcome between the two techniques of myotomy.

Description:

Peroral Endoscopic Myotomy (POEM) is an effective, minimally-invasive treatment for achalasia that has been adopted over the past few years. As more programs attempt to adopt the novel technique, there is an increased need for trials to help guide the growth of the procedure. Review of the current literature reveals that most endoscopists prefer an anterior approach, with an incision in the anterior/ anterolateral wall of the esophagus. This approach has been used with tremendous success in decreasing the symptoms of dysphagia and lowering esophageal sphincter (LES) pressure since the first description of the procedure in humans in 2010. However, it can be technically challenging in patients with anterior scarring from prior surgery or radiation, in whom a posterior approach has typically been used. Alternatively, the posterior approach, with incision in the posterolateral wall of the esophagus, has been adopted with great success by several endoscopists as the primary approach to myotomy. Reports involving the posterior approach have also shown significant symptom relief as defined by symptoms score (Eckardt score) < 3, decreased LES pressure, and low complication rates.

However, despite high rates of technical and clinical success, the posterior approach has not been as widely adopted as the anterior approach. Without comparison of the two approaches in terms of efficacy and safety, the optimal technique to myotomy for POEM is yet to be defined. The investigators main hypothesis is that the posterior myotomy is as efficacious as the anterior myotomy in terms of improvement of achalasia symptoms as indicated by reduction in the Eckardt score and LES pressure. Adaptation of both techniques may increase options in approach for routine POEM and increase the number of patients that are able to undergo the procedure, thereby promoting its applicability.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 150
• Est. completion date: November 2017
• Est. primary completion date: November 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria for Participants

• Adult patient age greater than 18 years old

• Confirmed diagnosis of achalasia via high resolution esophageal manometry (HREM)

Exclusion Criteria

• Previous surgery of the esophagus or stomach

• Active severe esophagitis

• Large lower esophageal diverticula

• Large > 3cm hiatal hernia

• Sigmoid esophagus

• Known gastroesophageal malignancy

• Inability to tolerate sedated upper endoscopy due to cardiopulmonary instability, severe pulmonary disease or other contraindication to endoscopy

• Cirrhosis with portal hypertension, varices, and/or ascites

• Pregnant or breastfeeding women (all women of child-bearing age will undergo urine pregnancy testing)

• Acute gastrointestinal bleeding

• Uncorrectable coagulopathy defined by INR > 1.5 or platelet < 50

Related Conditions & MeSH terms

• Achalasia
• Esophageal Achalasia

Intervention

Procedure:
• Peroral Endoscopic Myotomy
The intervention is the POEM procedure performed by either anterior approach or posterior approach orientation of the incision for mucosal entry.

Locations

Country	Name	City	State
United States	Johns Hopkins Hospital	Baltimore	Maryland

Sponsors (1)

Lead Sponsor	Collaborator
Johns Hopkins University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Eckardt Score	The standardized clinical scoring system for achalasia will be assessed at 2 weeks, 3 months, 6 months, and 1 year post procedure. The score is based on the results of a self- administered questionnaire using 4 items related to digestive symptoms including weight loss, dysphagia, retrosternal pain, and regurgitation. Each item is rated from 0 to 3 (0= none, 1= occasional, 2=daily, 3=with every meal).	up to 24 months
Secondary	Rate of GERD by pH-impedance	This is assessed by the DeMeester score. The score is comprised of the following: Percent total time pH < 4, Percent Upright time pH < 4, Percent Supine time pH < 4, Number of reflux episodes, Number of reflux episodes = 5 min, Longest reflux episode (minutes). The abnormal reflux is defined as DeMeester score >14.72	up to 24 months
Secondary	Quality of Life by QoL S36 questionnaire	The SF-36 general health questionnaire consists of 36 questions evaluating the patient's perception of their quality of life (QoL) in the following eight subscales: physical functioning (PF), role limitations due to physical problems (RP), role limitations due to emotional problems (RE), energy/fatigue (EF), emotional well-being (EW), social functioning (SF), bodily pain (BP) and general health (GH). Subscale scores range from 0 to 100, with 100 being the best and 0 being the worst quality of life.	up to 2 years
Secondary	Dysphagia by the Dysphagia Score	Dysphagia scoring system scores dysphagia as follows: 0 = able to eat normal diet / no dysphagia; 1 = able to swallow some solid foods; 2 = able to swallow only semi solid foods; 3 = able to swallow liquids only; 4 = unable to swallow anything / total dysphagia.	up to 24 months
Secondary	Postoperative pain by VAS analogue scale	The visual analogue scales scores the severity of the pain from zero (minimum) to 10 (maximum).	2 years
Secondary	Analgesic use by Analgesic Quantification Algorithm	Analgesic Quantification Algorithm scoring scores analgesic use from zero (minimum) to 7 (maximum) as follows: 0= No analgesic; 1= Non-opioid analgesics; 2= Weak opioids (For example, codeine and tramadol); 3= Strong opioids =75 mg OME per day; 4= Strong opioids >75-150 mg OME per day; 5= Strong opioids >150-300 mg OME per day; 6= Strong opioids >300-600 mg OME per day ; 7=Strong opioids >600 mg OME per day	up to 24 months
Secondary	Operative and post-operative complications		up to 2 years
Secondary	Hospital stay in days		up to 24 months
Secondary	LES pressure by Manometry		up to 2 years
Secondary	Total procedure time and times of different steps		up to 24 months
Secondary	Technical success	Defined as completion of the procedure using the assigned approach	up to 24 months
Secondary	Ease of procedure measured by the Lickerdt scale	The ease of the procedure scored by the endoscopist on a Likert scale rated from 1 (easy) to 5 (impossible).	up to 24 months